NCT00268593 Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer Status COMPLETED Phase PHASE2
NCT00268476 Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT00264420 Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation Status COMPLETED Phase PHASE1
NCT00263107 Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction. Status COMPLETED Phase N/A
NCT00261456 The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00258765 Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. Status TERMINATED Phase PHASE2
NCT00258466 Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer Status WITHDRAWN Phase PHASE3
NCT00258401 Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. Status COMPLETED Phase NA
NCT00258388 Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy Status COMPLETED Phase PHASE2
NCT00258284 Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00257478 A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT00255606 Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00253643 Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer Status COMPLETED Phase NA
NCT00252941 Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00250757 Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions Status TERMINATED Phase N/A
NCT00246753 Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00245895 Study of Aranesp to Treat Anemia in Prostate Cancer Patients. Status COMPLETED Phase PHASE2